Glycyrrhizin
(glycyrrhizic acid, glucuronido-glucuronide of 18,5-glycyrrhe tinic acid), occurring naturally in the root of glycyrrhiza glabra L., has been used either as a medicament for its desoxycorticosterone like (1) and cortisol-like (2) effects or as a food additive for its sweetness.
Glycyrrhizin, which is classified as a saponin, has a protective effect against hemolysis induced by other saponins or a cationic surfactant (3), though saponins are generally characterized by hemolytic action. Thus, it is probable that glycyrrhizin induces alteration in membrane fluidity by reacting with the components of membrane or intercalating its moiety into the membrane structure.
In this report, we tested biological actions of glycyrrhizin on lysosomes, chosen as a tentative membrane system, by 1) examining whether or not glycyrrhizin affects the hepatic lysosomal enzyme activity itself, and 2) measuring its in vitro release of lysosomal enzymes from the lysosome granules.
Glycyrrhizin was purchased from Nakarai Chemicals, LTD., and 18a or 18,3-glycyr rhetinic acid was obtained from Sigma Chemical Company. These compounds were used after dissolution in 5 /cl of dimethyl sulfoxide.
Hepatic lysosomes were prepared from male mice (ddY strain, 25-30 g of body weight) by centrifugation at 13,000xg for 10 min, according to the method of Wang et al. (4) .
When we determined direct effects of a test compound on the enzyme activity, we prepared crude enzyme samples by dissolving lysosomal particles (13,000xg pellet) with 0.1% Triton X-100.
Lysosomal enzyme activities were measured by the procedures described by Barret and Heath (5, 6) . Acid phosphatase (APh) activity was measured by incubating 0.3 ml of enzyme sample with 1.2 ml of 0.2M acetate buffer (pH 5.0) and 0.5 ml of 32 mM 4-nitrophenylphosphate for 20 min at 37'C, and successively adding 2.0 ml of ice-cold 1 M Tris-0.4 M phosphate buffer (pH 8.5) to terminate the reaction.
The assay of (3-N-acetylglucosaminidase (NAcG) activity was carried out under the following conditions. The incubation mixture contained 0.5 ml of enzyme sample, 0.5 ml of 0.3 M citrate-0.3 M NaCI buffer (pH 4.3), and 0.5 ml of 15 mM 4-nitrophenyl-4-N-acetyl glucosaminide. After incubation for 20 min at 37'C, the reaction was stopped by adding 1.5 ml of 0.5 M bicarbonate buffer (pH 10.0). In either case, the presence of the liberated 4-nitrophenol was determined spectrophoto metrically at 420 nm.
Integrity of lysosome membrane was ascertained by measuring the release of lysosomal marker enzymes. The release of lysosomal enzymes was induced by incubating for 15 min at 37°C 1.5 ml of lysosome suspension containing 10 mM Tris-HCI (pH 7.1) in 0.44 M sucrose-0.1 77 M KCI with a test compound in the presence or absence of 0.1% Triton X-100 in the final volume of 2.0 ml. In control experiments, the test compound was replaced by a vehicle. After cooling in ice-water, lysosomes were centrifuged at 13,000 X g for 10 min. A portion of the supernatant was removed for the assay of enzyme activity.
We regarded the enzyme activity in the supernatant of the sample treated with Triton X-100 as total recovered activity because sedimentary enzyme activity was negligible.
Therefore, alteration in total recovered activity may reflect changes in activity of the enzyme itself. Table 1 shows the effect of glycyrrhizin and its constituents on the activity of lysosomal enzymes which were prepared by solubilizing lysosome fraction with 0.1% Triton X-100. Both glycyrrhizin and 18,3-glycyrrhetinic acid, the aglycone of glycyrrhizin, attenuated APh activity significantly, but 1 8a-glycyr rhetinic acid and glucuronic acid showed no effects.
On the other hand, NAcG activity remained unchanged when adding of any the compounds listed above, in a dose of 3x10-4 M. Figure 1 shows that the release of APh was enhanced by the addition of glycyrrhizin or 18;3-glycyrrhetinic acid, but was reduced by 18a-glycyrrhetinic acid. Such was evident when the magnitude of the enzyme release was assessed by calculating the ratio of the enzyme activity in the supernatant without Triton X-1 00 (shaded area) to total recovered activity.
On and a decrease at 10-3 M.
It has been reported that glycyrrhizin is hydrolized to glucuronate and glycyrrhetinic acid at a low concentration by F3-glucuroni dase, a lysosomal enzyme, but inhibits /3 glucuronidase activity non-competitively at a high concentration (7). In addition, we have found that glucuronate had no effect on the lysosomal release of these enzymes (data are not shown).
Accordingly, it is probable that the increased release of enzyme in the presence of a low concentration of glycyr rhizin may be due to 18;3-aglycone as a result of the hydrolysis of glycyrrhizin, while the split of the saponin may be negligible at 10-3 M.
Segal and Milo-Goldzweig (8) reported that aldonolactones, which are specific glucosidase inhibitors, inhibited saponin-induced hemolysis, but showed no protective effect on the hemolysis induced by the sapogenins. The action of glycyrrhizin on the release of NAcG in our report resembles their findings in that a glycoside may stabilize the membrane, while its aglycone may not do so. plays an important role in the interaction with components of membrane. Furthermore, the hydrophilic moiety of glucuronate can modify the affinity of the aglycone for lipid layer of membrane by conferring an amphi pathic property, and thereby producing alteration in structure and/or fluidity of the membrane.
It is also likely that modes of existence of enzymes within lysosomes restrict the action of these drugs because APh and NAcG gave different responses to the same drug.
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